SERIAL QUANTITATION OF SERUM CORE PROTEIN AND VIRAL-RNA OF HEPATITIS-C VIRUS AFTER INTERFERON THERAPY - INCREASE IN VIRAL LOADS IN BIOCHEMICAL RESPONDERS
K. Yoshioka et al., SERIAL QUANTITATION OF SERUM CORE PROTEIN AND VIRAL-RNA OF HEPATITIS-C VIRUS AFTER INTERFERON THERAPY - INCREASE IN VIRAL LOADS IN BIOCHEMICAL RESPONDERS, The American journal of gastroenterology, 92(8), 1997, pp. 1305-1309
Objectives: Interferon (IFN) therapy is often ineffective in eradicati
ng hepatitis C virus (HCV). Some patients show normal serum ALT levels
for a long time after IFN therapy despite the presence of HCV. These
patients are considered not virological responders but biochemical res
ponders. We investigated the changes in the amount of HCV after IFN th
erapy in biochemical responders. Methods: Nine biochemical responders
and 11 nonresponders were studied. Serum HCV amount was measured by fl
uorescence enzyme immunoassay for HCV core (pg/ml) and Amplicor HCV Mo
nitor test for HCV RNA (logarithms of copy numbers per milliliter). Re
sults: In biochemical responders, core protein and HCV RNA were increa
sed significantly at 1 month after IFN therapy (291 +/- 191 pg/ml and
5.4 +/- 0.9, respectively; p < 0.05 for both) and at 1 yr (324 +/- 189
pg/ml and 5.6 +/- 0.7, respectively; p < 0.01 for both) compared with
pretreatment values (122 +/- 114 pg/ml and 4.8 +/- 0.9, respectively)
. The change ratios of core protein at 1 month and 6 months after ther
apy to the pretreatment values were significantly higher in biochemica
l responders (3.2 +/- 2.4 and 2.9 +/- 2.3, respectively) than in nonre
sponders (0.9 +/- 0.7 and 1.1 +/- 0.8, respectively) (p < 0.05 for bot
h). Similarly, the change ratios of HCV RNA at 1 month and 1 yr after
IFN therapy were significantly higher in biochemical responders (9.9 /- 14.6 and 12.8 +/- 15.1) than in nonresponders (0.6 +/- 0.5 and 1.2
+/- 1.2) (p < 0.05 for both). Conclusions: HCV amount increased signif
icantly after IFN therapy in biochemical responders, whereas it did no
t change notably in nonresponders.